Gracell Biotechnologies (GRCL) Earnings Date, Estimates & Call Transcripts → SHOCKING Crypto Leak… (From Crypto 101 Media) (Ad) Free grcl Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share EarningsStock AnalysisAnalyst ForecastsEarningsHeadlinesOwnershipShort InterestSocial MediaStock AnalysisAnalyst ForecastsEarningsHeadlinesOwnershipShort InterestSocial Media Skip Charts & View Estimated and Actual Earnings DataEarnings Per ShareRevenueGRCL Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.GRCL Estimated and Actual Revenue by Quarter Estimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Ad Stansberry ResearchGlobal crypto currency reset (41 major banks signed up)Behind closed doors, at least 41 major US banks have signed up to a strange new crypto project... Here's everything you need to know. Gracell Biotechnologies Analyst EPS EstimatesCurrent Year EPS Consensus Estimate:($0.92) EPSNext Year EPS Consensus Estimate: ($0.97) EPS Gracell Biotechnologies Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript11/13/2023Q3 2023($0.26)($0.10)+$0.16($0.10)--8/14/2023Q2 2023($0.37)($0.30)+$0.07($0.30)--5/15/2023Q1 2023($0.35)($0.35)-($0.35)--3/13/2023Q4 2022($0.43)($0.30)+$0.13($0.30)-- 11/14/2022Q3 2022($0.09)($0.36)($0.27)($0.36)-- 8/15/2022Q2 2022($0.08)($0.32)($0.24)($0.32)-- Get the Latest News and Ratings for GRCL and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Gracell Biotechnologies and its competitors with MarketBeat's FREE daily newsletter. 5/16/2022Q1 2022($0.08)($0.37)($0.29)($0.37)-- 3/14/2022Q4 2021($0.38)($0.30)+$0.08($0.30)-- 11/14/2021Q3($0.12)($0.30)($0.18)($0.06)-$0.06 million8/16/2021Q2 2021($0.12)($0.20)($0.08)($0.22)-- 5/16/2021Q1($0.2130)($0.25)($0.0370)($0.25)-- Gracell Biotechnologies Earnings - Frequently Asked Questions How much revenue does Gracell Biotechnologies generate each year? Gracell Biotechnologies (NASDAQ:GRCL) has a recorded annual revenue of $60,000.00. How much profit does Gracell Biotechnologies generate each year? Gracell Biotechnologies (NASDAQ:GRCL) has a recorded net income of -$88.08 million. GRCL has generated -$1.05 earnings per share over the last four quarters. What is Gracell Biotechnologies's EPS forecast for next year? Gracell Biotechnologies's earnings are expected to decrease from ($0.92) per share to ($0.97) per share in the next year. More Earnings Resources from MarketBeat Related Companies: Icosavax Earnings Date Dianthus Therapeutics Earnings Date Wave Life Sciences Earnings Date Cogent Biosciences Earnings Date Allogene Therapeutics Earnings Date Stoke Therapeutics Earnings Date Celcuity Earnings Date Corbus Pharmaceuticals Earnings Date Shattuck Labs Earnings Date Harpoon Therapeutics Earnings Date Earnings Tools: Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country: U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Australia Earnings Reports Latest Articles: Taiwan Semiconductor Earnings: AI Dominance and Future OutlookCSX Co.: The Railroad Powering Ahead with an Earnings Beat What's Driving Tesla Lower Ahead of its Earnings?Blackrock vs. State Street: Earnings in a Volatile MarketWhat to Expect From the Q1 Earnings Reporting SeasonLululemon Stock Implodes Post Earnings, Guidance Muted Applied Optoelectronics earnings dumper, pain now for gain later? This page (NASDAQ:GRCL) was last updated on 4/24/2024 by MarketBeat.com Staff From Our Partnerstop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencySHOCKING Crypto Leak…Crypto 101 MediaYour Money is Not SafeAmerican AlternativeDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsGlobal crypto currency reset (41 major banks signed up)Stansberry ResearchDon’t Miss Out on the AI Gold Rush That’s Just Getting StartedBanyan Hill PublishingMan Who Predicted 2008: “This Will be Worse.”AltimetryEmergency: Biden's $20 Trillion Mistake Could Cost YOU!GoldenCrest Metals Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Gracell Biotechnologies Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
